Syk阻害薬 | NDL Search | National Diet Library

Syk阻害薬

Material type: 文書・図像類

Author: 木村, 幸弘ほか

Publisher: 株式会社日本臨床社

Publication date: 2013-07

Material Format: Digital

Capacity, size, etc.: -

NDC: -

View All

Notes on use

Note (General)：: Non-receptor type of protein-tyrosine kinase Syk(spleen tyrosine kinase) was isolated in the University of Fukui in 1991. Syk is kmown to beessential ...

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

List of Cooperating Institutions and Databases

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

Ｕｎｉｖｅｒｓｉｔｙ　ｏｆ　Ｆｕｋｕｉ　Ａｃａｄｅｍｉｃ　Ｒｅｐｏｓｉｔｏｒｙ
Digital
You can check the holdings of institutions and databases with which 学術機関リポジトリデータベース（IRDB）（機関リポジトリ） is linked at the site of 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）.
Ｕｎｉｖｅｒｓｉｔｙ　ｏｆ　Ｆｕｋｕｉ　Ａｃａｄｅｍｉｃ　Ｒｅｐｏｓｉｔｏｒｙ

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 文書・図像類
Title: Syk阻害薬
Author/Editor: 木村, 幸弘
千葉, 一泰
竹内, 健司
定, 清直
Author Heading: 木村, 幸弘
千葉, 一泰
竹内, 健司
定, 清直
Publication, Distribution, etc.: 株式会社日本臨床社
Publication Date: 2013-07
Publication Date (W3CDTF): 2013-07
Periodical title: 日本臨床
No. or year of volume/issue: 71 7
Volume: 71
Issue: 7
Pages: 1248-1252
Text Language Code: jpn
Subject Heading: Syk
Syk inhibitors
rheumatoid arthritis
Target Audience: 一般
Note (General): Non-receptor type of protein-tyrosine kinase Syk(spleen tyrosine kinase) was isolated in the University of Fukui in 1991. Syk is kmown to beessential for the various physiological functions, especially in hematopoietic ineage cells. Moreover, ectopic expression of Syk by epigenetic changes is reported to cause etinoblastoma. Recently, novel Syk inhibitors were developed and its usefulness has been evaluated in thetreatment of allergi crhinitis, rheumatoid arthritis, and idiopathic thrombocytopenic purpura. In this review, we will summarize the history, structure, and function of Syk, and then describe the novel Syk inhibitors and their current status, Furthermore, we will introduce our findings of the adap-tor protein 3BP2(c-Abl SH3 domain-binding protein-2), as a novel target of Syk.
Source: https://u-fukui.repo.nii.ac.jp/?action=repository_action_common_download&item_id=20286&item_no=1&attribute_id=22&file_no=1
https://u-fukui.repo.nii.ac.jp/?action=repository_action_common_download&item_id=20286&item_no=1&attribute_id=22&file_no=1
Access Restrictions: 限定公開
Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）
https://irdb.nii.ac.jp
Original Data Provider (Database): 福井大学 : 福井大学学術機関リポジトリ